NEW YORK (GenomeWeb) – LGC said today that it has appointed Sigma-Aldrich as the exclusive global distributor of its off-the-shelf KASP Genotyping Assays.

The three-year deal includes more than 100,000 pre-designed assays for public domain human SNPs. In addition, Sigma-Aldrich will non-exclusively distribute LGC's KASP MasterMix reagents, custom KASP Laboratory Validated Assays, and custom KASP Designed Assays, LGC said.

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.